Location History:
- Linden, NJ (US) (2008 - 2013)
- Scotch Plains, NJ (US) (2011 - 2020)
Company Filing History:
6 out of 2,405 
4 out of 1,829 
1 out of 40 
Years Active: 2008-2020
Title: Thomas A Bara: Innovator in Pharmaceutical Compounds
Introduction
Thomas A Bara is a notable inventor based in Linden, NJ (US), recognized for his contributions to the field of pharmaceuticals. With a total of 11 patents, he has made significant advancements in the development of compounds that address various health conditions.
Latest Patents
Among his latest patents, Thomas has developed hydroxy isoxazole compounds that serve as GPR120 agonists. These compounds are particularly useful for treating or preventing diabetes, hyperlipidemia, obesity, NASH, inflammation-related disorders, and other related diseases. The invention includes pharmaceutical compositions and methods of treatment utilizing these compounds. Additionally, he has created Factor XIa inhibitors, which are compounds designed to treat or prevent thromboses, embolisms, hypercoagulability, or fibrotic changes. These compounds are selective inhibitors of Factor XIa or dual inhibitors of Factor XIa and plasma Kallikrein.
Career Highlights
Throughout his career, Thomas A Bara has worked with prominent companies such as Merck Sharp & Dohme Corp. and Schering Corporation. His work in these organizations has contributed to the development of innovative pharmaceutical solutions.
Collaborations
Thomas has collaborated with notable coworkers, including Hubert B Josien and John W Clader, enhancing the impact of his research and inventions.
Conclusion
Thomas A Bara's innovative work in pharmaceutical compounds has led to significant advancements in treating various health conditions. His contributions continue to influence the field and improve patient outcomes.